IGC PHARMA INC (IGC)
US45408X3089 - Common Stock
| MRQ (2023-12-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.38M | 3.20M | 10.46M | 14.55M | 7.26M | |||
| Marketable Securities | 0.00 | 150.00K | 0.00 | 80.00K | 5.08M | |||
| Receivables | 108.00K | 130.00K | 600.00K | 1.92M | 130.00K | |||
| Inventories | 1.93M | 2.65M | 3.55M | 5.48M | 4.25M | |||
| Other Current Assets | 172.00K | 330.00K | 510.00K | 1.50M | 1.04M | |||
| Total Current Assets | 3.58M | 6.47M | 15.11M | 23.52M | 17.76M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.50M | 8.54M | 9.87M | 11.33M | 10.35M | |||
| Investments And Advances | N/A | N/A | 0.00 | 10.00K | 10.00K | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 1.18M | 1.17M | 920.00K | 410.00K | 250.00K | |||
| Other Non-Current Assets | 999.00K | 1.00M | 940.00K | 600.00K | 610.00K | |||
| Total Non-Current Assets | 7.68M | 10.71M | 11.72M | 12.35M | 11.22M | |||
| TOTAL ASSETS | 11.26M | 17.18M | 26.83M | 35.87M | 28.98M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 3.00K | 0.00 | 0.00 | 300.00K | 50.00K | |||
| Accrued Expenses | 869.00K | 750.00K | 1.18M | 940.00K | 510.00K | |||
| Accounts Payable | 648.00K | 530.00K | 980.00K | 480.00K | 760.00K | |||
| Other Current Liabilities | 416.00K | 610.00K | 280.00K | 650.00K | 620.00K | |||
| Total Current Liabilities | 1.94M | 1.90M | 2.44M | 2.37M | 1.95M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 138.00K | 140.00K | 140.00K | 280.00K | 0.00 | |||
| Other Non-Current Liabilities | 132.00K | 230.00K | 360.00K | 420.00K | 500.00K | |||
| Total Non-Current Liabilities | 270.00K | 370.00K | 500.00K | 690.00K | 500.00K | |||
| TOTAL LIABILITIES | 2.21M | 2.27M | 2.94M | 3.06M | 2.45M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -110.78M | -100.67M | -89.16M | -74.14M | -65.37M | |||
| Additional Paid In Capital | N/A | N/A | N/A | N/A | 94.75M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 123.26M | 118.97M | 116.02M | 109.72M | 0.00 | |||
| Other Shareholders' Equity | -3.42M | -3.39M | -2.97M | -2.77M | -2.85M | |||
| Shares Outstanding | 63.73M | 53.08M | 51.05M | 47.83M | 39.32M | |||
| Tangible Book Value per Share | 0.12 | 0.26 | 0.45 | 0.68 | 0.67 | |||
| Total Shareholders' Equity | 9.05M | 14.91M | 23.89M | 32.80M | 26.54M | |||
| TOTAL LIABILITIES AND EQUITY | 11.26M | 17.18M | 26.83M | 35.87M | 28.98M | |||
| Statistics | ||||||||
| Debt/Equity | 0.02 | 0.01 | 0.01 | 0.01 | N/A | |||
| Current Ratio | 1.85 | 3.41 | 6.19 | 9.92 | 9.11 | |||
| Return On Assets (ROA) | -125.67% | -67.00% | -55.98% | -24.56% | -25.26% | |||
| Return On Equity (ROE) | -156.29% | -77.20% | -62.87% | -26.86% | -27.58% | |||
All data in USD